Fundz

Onco Response reported raising $6 Million in an initial SEC Form D filing

PRIVATEMay 06, 2025

Amount Raised

$6 Million

$6 Million sold, per SEC Form D (first sale Apr 21, 2025)

Round Type

Venture

HoustonBiotechnology

Investors

Helsinn GroupCanaan PartnersArch Venture PartnersGreatpoint Ventures

Who to call at OncoResponse, and when

A new round usually means OncoResponse is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day OncoResponse raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at OncoResponse, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at OncoResponse. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

OncoResponse

Location

609 MAIN STREET

Houston, Texas, United States

About

OncoResponse is a clinical stage, privately held immuno-oncology biotech company developing cancer immunotherapies using clues from the immune systems of elite cancer responders. In a broad strategic alliance with MD Anderson Cancer Center, OncoResponse deploys a proprietary B-cell discovery platform to identify and develop novel therapeutics targeting the tumor microenvironment. The company’s lead candidate, OR2805, has entered clinical studies with a unique and transformative approach to the advancement of cancer therapeutics.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment OncoResponse raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contacts17 people are listed at OncoResponse. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for OncoResponse's next move

See what Strategic adds

OncoResponse raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.